Relationship between plasma lipoprotein (a), apolipoprotein (a) phenotypes, and other coronary heart disease risk factors in a Melbourne South Asian population

ZW Xiong, ML Wahlqvist, TI Ibiebele, BM Biegler… - Clinical …, 2004 - Elsevier
Background: High plasma lipoprotein (a)[Lp (a)] level is a strong and important risk factor for
cardiovascular disease (CVD). Small-sized apolipoprotein (a)[apo (a)] isoforms (F, B, S1 …
被引用次数：12 相关文章
[PDF] academia.edu

[PDF][PDF] Relationship between plasma lipoprotein (a), apolipoprotein (a) phenotypes, and other coronary heart disease risk factors in a Melbourne South Asian …

ZW Xiong, ML Wahlqvist, TI Ibiebele, BM Biegler… - Clinical …, 2004 - academia.edu
Background: High plasma lipoprotein (a)[Lp (a)] level is a strong and important risk factor for
cardiovascular disease (CVD). Small-sized apolipoprotein (a)[apo (a)] isoforms (F, B, S1 …

[引用][C] Relationship between plasma lipoprotein (a), apolipoprotein (a) phenotypes, and other coronary heart disease risk factors in a Melbourne South Asian …

ZW Xiong, ML Wahlqvist, T Ibiebele… - Clinical …, 2004 - research.monash.edu
Relationship between plasma lipoprotein (a), apolipoprotein (a) phenotypes, and other coronary
heart disease risk factors in a Melbourne South Asian population — Monash University Skip to …

Relationship between plasma lipoprotein (a), apolipoprotein (a) phenotypes, and other coronary heart disease risk factors in a Melbourne South Asian population

ZW Xiong, ML Wahlqvist, TI Ibiebele… - Clinical …, 2004 - pubmed.ncbi.nlm.nih.gov
Background High plasma lipoprotein (a)[Lp (a)] level is a strong and important risk factor for
cardiovascular disease (CVD). Small-sized apolipoprotein (a)[apo (a)] isoforms (F, B, S1 …
[PDF] psu.edu

[PDF][PDF] Relationship between plasma lipoprotein (a), apolipoprotein (a) phenotypes, and other coronary heart disease risk factors in a Melbourne South Asian …

ZW Xiong, ML Wahlqvist, TI Ibiebele, BM Biegler… - Clinical …, 2004 - Citeseer
Background: High plasma lipoprotein (a)[Lp (a)] level is a strong and important risk factor for
cardiovascular disease (CVD). Small-sized apolipoprotein (a)[apo (a)] isoforms (F, B, S1 …

Relationship between plasma lipoprotein (a), apolipoprotein (a) phenotypes, and other coronary heart disease risk factors in a Melbourne South Asian population.

ZW Xiong, ML Wahlqvist, TI Ibiebele… - Clinical …, 2004 - europepmc.org
Background High plasma lipoprotein (a)[Lp (a)] level is a strong and important risk factor for
cardiovascular disease (CVD). Small-sized apolipoprotein (a)[apo (a)] isoforms (F, B, S1 …

Relationship between plasma lipoprotein (a), apolipoprotein (a) phenotypes, and other coronary heart disease risk factors in a Melbourne South Asian population

ZW Xiong, ML Wahlqvist, TI Ibiebele, BM Biegler… - Clinical …, 2004 - infona.pl
Background: High plasma lipoprotein (a)[Lp (a)] level is a strong and important risk factor for
cardiovascular disease (CVD). Small-sized apolipoprotein (a)[apo (a)] isoforms (F, B, S1 …
[PDF] nhri.org.tw

[PDF][PDF] Relationship between plasma lipoprotein (a), apolipoprotein (a) phenotypes, and other coronary heart disease risk factors in a Melbourne South Asian …

ZW Xiong, ML Wahlqvist, TI Ibiebele… - Clinical …, 2004 - apjcn.nhri.org.tw
Background: High plasma lipoprotein (a)[Lp (a)] level is a strong and important risk factor for
cardiovascular disease (CVD). Small-sized apolipoprotein (a)[apo (a)] isoforms (F, B, S1 …
[PDF] nhri.org.tw

[PDF][PDF] Relationship between plasma lipoprotein (a), apolipoprotein (a) phenotypes, and other coronary heart disease risk factors in a Melbourne South Asian …

ZW Xiong, ML Wahlqvist, TI Ibiebele… - Clinical …, 2004 - apjcn.nhri.org.tw
Background: High plasma lipoprotein (a)[Lp (a)] level is a strong and important risk factor for
cardiovascular disease (CVD). Small-sized apolipoprotein (a)[apo (a)] isoforms (F, B, S1 …

[引用][C] Relationship between plasma lipoprotein (a), apolipoprotein (a) phenotypes, and other coronary heart disease risk factors in a Melbourne South Asian …

ZWEI XIONG, ML WAHLQVIST, TI IBIEBELE… - Clinical …, 2004 - Elsevier